Table 4.

Impact of T gondii on Angiogenic Regulators in Different Mice Groups.^a

	C	T gondii	EAC	EAC + T gondii
VEGF	1.00 ± .015b	1.36 ± 0.16b	10.19 ± 0.2a	5.34 ± 0.28a,b
Integrin	1.02 ± 0.01b	1.15 ± 0.05b	7.06 ± 0.29a	3.66 ± 0.3a,b
MMP2	1.014 ± 0.015b	1.12 ± 0.05b	5.53 ± 0.31a	3.02 ± 0.22a,b
MMP9	1.00 ± 0.015b	1.17 ± 0.04b	6.06 ± 0.29a	2.94 ± 0.47a,b
NO, nmol/mL	10.16 ± 0.6b	8.86 ± 0.3b	32.32 ± 2.94a	14.83 ± 0.35a,b

Abbreviation: C, normal control mice; EAC, mice inoculated with Ehrlich ascites carcinoma; MMP, matrix metallopeptidase; NO, nitric oxide; SE, standard error; T gondii, mice treated with gamma attenuated Toxoplasma gondii; VEGF, vascular endothelial growth factor.

Each value represents the mean ± SE (n = 6).

^asignificantly different from control.

^bsignificantly different from EAC.